| Serial Number | 97512123 |
| Word Mark | SATIO |
| Filing Date | Wednesday, July 20, 2022 |
| Status | 731 - SECOND EXTENSION - GRANTED |
| Status Date | Wednesday, September 18, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, September 5, 2023 |
| Goods and Services | Vaccines, namely, dermal patches featuring vaccines; pharmaceutical preparations for the prevention and treatment of infectious diseases and non-infectious diseases, namely, dermal patches featuring pharmaceutical preparations for the prevention and treatment of hepatic diseases, immune system diseases, renal diseases, metabolic diseases, endocrine diseases, thyroid diseases, diabetes, pancreatic diseases, cystic fibrosis, phenylketonuria, blood diseases, sickle cell disease, sickle cell anemia, galactosemia, and glucose-6-phosphate dehydrogenase (G6PD) deficiency; medical diagnostic reagents and assays for testing of body fluids, namely, dermal patches featuring medical diagnostics or assays for testing of body fluids; reagents for use in medical genetic testing, namely, dermal patches featuring reagents for use in medical genetic testing |
| Goods and Services | Medical diagnostic apparatus for testing DNA and RNA samples; medical diagnostic apparatus for testing for infectious diseases and non-infectious diseases, namely, hepatic diseases, immune system diseases, renal diseases, metabolic diseases, endocrine diseases, thyroid diseases, diabetes, pancreatic diseases, cystic fibrosis, phenylketonuria, blood diseases, sickle cell disease, sickle cell anemia, galactosemia, and glucose-6-phosphate dehydrogenase (G6PD) deficiency; genetic testing apparatus for medical purposes; dermal patches for delivery of pharmaceuticals and vaccines, sold empty; medical devices for obtaining body fluid samples; medical devices for testing body fluid samples; dermal patches for testing DNA and RNA samples; dermal patches for testing for infectious diseases and non-infectious diseases, namely, hepatic diseases, , immune system diseases, renal diseases, metabolic diseases, endocrine diseases, thyroid diseases, diabetes, pancreatic diseases, cystic fibrosis, phenylketonuria, blood diseases, sickle cell disease, sickle cell anemia, galactosemia, and glucose-6-phosphate dehydrogenase (G6PD) deficiency; dermal patches for testing for genetic testing; dermal patches for obtaining body fluid samples; dermal patches for testing body fluid samples |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, August 10, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, August 10, 2022 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Satio, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Boston, MA 02210 |
| Party Name | Satio, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Boston, MA 02210 |
| Event Date | Event Description |
| Saturday, July 23, 2022 | NEW APPLICATION ENTERED |
| Wednesday, August 10, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, May 5, 2023 | ASSIGNED TO EXAMINER |
| Wednesday, May 17, 2023 | PRIORITY ACTION WRITTEN |
| Wednesday, May 17, 2023 | PRIORITY ACTION E-MAILED |
| Wednesday, May 17, 2023 | NOTIFICATION OF PRIORITY ACTION E-MAILED |
| Thursday, May 18, 2023 | PRIORITY ACTION WRITTEN |
| Thursday, May 18, 2023 | PRIORITY ACTION E-MAILED |
| Thursday, May 18, 2023 | NOTIFICATION OF PRIORITY ACTION E-MAILED |
| Thursday, July 27, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, July 27, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, July 28, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Saturday, July 29, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, August 16, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, September 5, 2023 | PUBLISHED FOR OPPOSITION |
| Tuesday, September 5, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, October 24, 2023 | TEAS POST PUBLICATION AMENDMENT RECEIVED |
| Tuesday, October 31, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Thursday, November 9, 2023 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Wednesday, November 29, 2023 | NOTICE OF ALLOWANCE CORRECTION ENTERED |
| Friday, April 26, 2024 | SOU EXTENSION 1 FILED |
| Thursday, November 30, 2023 | CORRECTED NOA E-MAILED |
| Friday, April 26, 2024 | SOU TEAS EXTENSION RECEIVED |
| Friday, April 26, 2024 | SOU EXTENSION 1 GRANTED |
| Wednesday, September 18, 2024 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, September 18, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, September 18, 2024 | SOU EXTENSION 2 FILED |
| Wednesday, September 18, 2024 | SOU EXTENSION 2 GRANTED |
| Saturday, April 27, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |